Home / Market News / $SRZN

$SRZN news and market catalysts

The 5 most recent market catalysts affecting $SRZN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 0 high impact 2 bullish 0 bearish Biotechnology
Nov 9, 2026 Corporate Catalyst Neutral Impact 75
Surrozen Reports Third Quarter 2026 Financial Results and Business Update
Surrozen reported a substantial net loss of $129.7 million for Q3 2026, primarily driven by a non-cash loss related to warrant and tranche liabilities. While the headline loss is s…
Nov 5, 2026 Corporate Catalyst Neutral Impact 55
Surrozen, Inc. Schedules Third Quarter 2026 Earnings Announcement
This 8-K filing announces the date and time for Surrozen, Inc.'s third-quarter 2026 earnings release, along with consensus analyst estimates for revenue and EPS. This is a routine …
Sep 25, 2026 Corporate Catalyst Bullish Impact 65
HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $54
HC Wainwright & Co. analyst Matthew Caufield has maintained a 'Buy' rating on Surrozen (SRZN) and raised the price target from $44 to $54. This upgrade in price target indicates in…
Sep 24, 2026 Corporate Catalyst Bullish Impact 75
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
Surrozen Inc. announced the submission of an Investigational New Drug (IND) application to the FDA for SZN-8141, targeting diabetic macular edema. This is a critical milestone for …
Aug 10, 2026 Corporate Catalyst Neutral Impact 55
HC Wainwright & Co. Reiterates Buy on Surrozen, Maintains $44 Price Target
This 8-K filing discloses that HC Wainwright & Co. analyst Matthew Caufield has reiterated a 'Buy' rating for Surrozen (SRZN) and maintained a $44 price target. This action signals…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.